Видео с ютуба Curevac

CureVac Tübingen - A great place to work

Durmitor National Park: Hiking to the Curevac Viewpoint

Why is Germany's CureVac vaccine just 48% effective? | Covid-19 Special

CureVac: About mRNA technology

BioNTech kauft CureVac – was Anleger jetzt wissen müssen!

BioNTech übernimmt CureVac: Aktie vor Krebs-Durchbruch?

Episode 1 | Leaving Ego Aside – Inside the CureVac–BioNTech Deal

A Tale of Two mRNA-based Vaccines: BioNTech vs. CureVac

CureVac Bioprocessing Equipment Auction – Dec 10-11, 2024

Labiotech Tour South Germany 2014: CureVac with CEO Ingmar Hoerr

CureVac Headquarters in Tübingen, Germany

CureVac CFO Sees ‘No Strings Attached’ to German Investment

Spotlight on CureVac – the RNA people

CureVac CEO on the company's IPO and Covid-19 vaccine research

CureVac hopes to utilize innovations in mRNA to transform the medicines of today

CureVac fails in pivotal COVID-19 vaccine trial

Corona-Impfstoff: Schwerer Dämpfer für CureVac

Kolejna szczepionka mRNA CureVac

CureVac is focusing on mRNA cancer vaccines, CFO says